MX2010004852A - Combinacion antihelmintica. - Google Patents

Combinacion antihelmintica.

Info

Publication number
MX2010004852A
MX2010004852A MX2010004852A MX2010004852A MX2010004852A MX 2010004852 A MX2010004852 A MX 2010004852A MX 2010004852 A MX2010004852 A MX 2010004852A MX 2010004852 A MX2010004852 A MX 2010004852A MX 2010004852 A MX2010004852 A MX 2010004852A
Authority
MX
Mexico
Prior art keywords
combination
anthelmintic combination
anthelmintic
compositions
controlling
Prior art date
Application number
MX2010004852A
Other languages
English (en)
Spanish (es)
Inventor
Hyun Sun Cho
Fabiando Peterson Lopes
Alvimar Costa
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2010004852A publication Critical patent/MX2010004852A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • C07D235/32—Benzimidazole-2-carbamic acids, unsubstituted or substituted; Esters thereof; Thio-analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2010004852A 2007-11-09 2008-11-07 Combinacion antihelmintica. MX2010004852A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07120380 2007-11-09
PCT/EP2008/065126 WO2009060063A1 (en) 2007-11-09 2008-11-07 Anthelmintic combination

Publications (1)

Publication Number Publication Date
MX2010004852A true MX2010004852A (es) 2010-06-02

Family

ID=39059330

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010004852A MX2010004852A (es) 2007-11-09 2008-11-07 Combinacion antihelmintica.

Country Status (7)

Country Link
CN (1) CN101848710A (pt)
AR (1) AR069223A1 (pt)
AU (1) AU2008324095A1 (pt)
BR (1) BRPI0820260A2 (pt)
MX (1) MX2010004852A (pt)
WO (1) WO2009060063A1 (pt)
ZA (1) ZA201002315B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2475430B1 (en) * 2009-09-07 2018-01-24 Argenta Manufacturing Limited Granulated anthelmintic preparations and delivery systems
HUE032885T2 (en) * 2011-12-20 2017-12-28 Ectin Res Ab A synergistic combination of avermectins and a nsaid to inhibit tumors
CN102743403A (zh) * 2012-06-26 2012-10-24 格特生物制药（天津）有限公司 一种家畜用驱虫片剂及其制备方法
CN102726443B (zh) * 2012-07-12 2013-11-27 中国林业科学研究院亚热带林业研究所 依维菌素与敌百虫复配农药
RU2699799C1 (ru) * 2019-01-10 2019-09-11 Федеральное государственное бюджетное учреждение науки Сибирский федеральный научный центр агробиотехнологий Российской академии наук (СФНЦА РАН) Противопаразитарная композиция и способ ее применения для лечения паразитозов жвачных животных
CN113755610B (zh) * 2021-10-08 2023-09-12 内蒙古自治区农牧业科学院 用于检测捻转血矛线虫对伊维菌素敏感性的基因及应用
CN114452314A (zh) * 2022-01-12 2022-05-10 河南百草元兽药有限公司 一种阿苯达唑伊维菌素粉及其制备方法
CN114569561A (zh) * 2022-03-28 2022-06-03 中牧实业股份有限公司黄冈动物药品厂 一种阿苯达唑伊维菌素粉及其制备方法与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1069032C (zh) * 1997-03-27 2001-08-01 中国农业大学 一种含阿维菌素/依维菌素的兽用抗寄生虫药
AU2003900505A0 (en) * 2003-02-05 2003-02-20 Jurox Pty Ltd Anthelmintic composition

Also Published As

Publication number Publication date
AU2008324095A1 (en) 2009-05-14
AR069223A1 (es) 2010-01-06
CN101848710A (zh) 2010-09-29
WO2009060063A1 (en) 2009-05-14
BRPI0820260A2 (pt) 2015-05-26
ZA201002315B (en) 2010-11-24

Similar Documents

Publication Publication Date Title
MX2010004852A (es) Combinacion antihelmintica.
MY153921A (en) Aminopyrazole derivatives
MX2009007254A (es) Composiciones de tableta en tableta.
NO20091133L (no) Anvendelse av 2-6-(3-amino-piperidin-L-yl)-3-metyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmetyl-4-fluor-benzonitril
EP1981527A4 (en) THERMALLY TARGET DELIVERY OF DRUGS SUCH AS DOXORUBICIN
IL192763A (en) History of pyrimidine, preparations containing them and used in the preparation of cancer drugs
HK1128471A1 (en) Heterocyclic non-nucleoside compounds, their preparation, pharmaceutical composition and their use as antiviral agents
HK1139854A1 (en) Fast-dissolving disintegrating film preparation having high proportion of active agent
MY153985A (en) Aminotriazole derivatives as alx agonists
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
MY153975A (en) Pyridine derivatives as s1p1/edg1 receptor modulators
MX2009011578A (es) 6-fenilpirimidinonas como moduladores de pim.
IL194800A0 (en) Pre-mixed, ready-to-use pharmaceutical compositions
MX2009010167A (es) Composicion farmaceutica solida que comprende un derivado de bencimidazol-7-carboxilato y un agente para el control del ph.
IL216176A (en) Derivatives (3'-fluoro-4'-hydroxymethyl-5 '- (methylsulfonyl) biphenyl-4-yl) -2-phenylalkyl- (h1-imidazole-4-yl) propane-2-ol and pharmaceuticals containing them
WO2010009200A3 (en) Methods for treating oral cavity infections with chlorine dioxide
MX2010001574A (es) Ligandos del receptor cannabinoide.
WO2006136580A3 (en) 2-(phenylamino)benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels
BRPI0910912A2 (pt) Composto, prodroga, ativador de glicocinase, agente farmacêutico, e, uso do composto
EA200900958A1 (ru) Препарат невирапина пролонгированного высвобождения
WO2007133944A3 (en) Topical administration of acyclovir
MY158253A (en) Cycloalkyloxy- and heterocycloalkyloxypyridine compounds as modulators of the histamine h3 receptor
BRPI0813094A2 (pt) Derivados de 1,2,3,4-tetra-hidro pirrolo (1,2-a) pirazina-6-carboxamidas e de 2,3,4,5-tetra hidro pirrolo (1,2-a) (1,4)-diazepina-7-carboxamidas, o respectivo preparo e a respectiva aplicação em terapêutica.
CL2012002543A1 (es) Composicion endoparasiticida que comprende una combinacion de un compuesto de formula (i) derivado de amidoacetonitrilo y abamectina; y su uso para el control de endoparasitos, en particular helmintos.
WO2007099555A3 (en) Pharmaceutical tablet compositions containing irbesartan

Legal Events

Date Code Title Description
FA Abandonment or withdrawal